Replies to post #13725 on GTC Biotherapeutics (fka GTCB)

[go seek]

Could a partnership for GTC's CD-137 occur while compound is in preclinic?

perhaps there are other reasons for delay in FDA meeting on design of clinical program... a refocus in the preclinical work based on findings to date.